Emergent BioSolutions EBS
NYSE EBS
$6.24 +0.04 (+0.65%)
As of: Oct 22, 2026 · 2:27 PM EDT

Emergent BioSolutions (EBS) Change in Other Operating Assets (2010 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Change in Other Operating Assets (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn -
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn -122.00 Mn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn 188.00 Mn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn -
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn -
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn 13.00 Mn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn -
10 Emergent BioSolutions 322.50 Mn -428.40 Mn 137.20 Mn 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 500,000.00
Dec 31, 2025 15.40 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 -19.70 Mn
Mar 31, 2025 -9.50 Mn
Dec 31, 2024 -23.60 Mn
Sep 30, 2024 13.70 Mn
Jun 30, 2024 -166.00 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 -30.00 Mn
Sep 30, 2023 500,000.00
Jun 30, 2023 13.30 Mn
Mar 31, 2023 4.50 Mn
Dec 31, 2022 -14.40 Mn
Sep 30, 2022 14.90 Mn
Jun 30, 2022 2.80 Mn
Mar 31, 2022 16.60 Mn
Dec 31, 2021 -62.50 Mn
Sep 30, 2021 52.40 Mn
API Access

Emergent BioSolutions Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY